Cointime

Eden Biologics

company

About

Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.

  • 51 - 100

Highlights

Total Funding Amount
$80M
Funding Rounds
2
Investors
1
Investments
2

Details

Last Funding Type
Post-IPO Equity
Industries
Biopharma,Biotechnology,Health Care,Health Diagnostics,Medical,Pharmaceutical
Founded date
Jan 1, 2012
Number Of Employee
51 - 100
Operating Status
Active

Eden Biologics, formerly known as JHL Biotech ("JHL") , is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners through the provision of contract development and manufacturing services. We are specialists in manufacturing biologics, from cell line development to commercial manufacturing with both global and regional regulatory affairs expertise.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$80M
Eden Biologics has raised a total of $80M in funding over 2 rounds. Their latest funding was raised on Oct 2, 2018 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 2, 2018 Post-IPO Equity — 1 Sanofi — Detail
Dec 5, 2016 Private Equity（PE） $80M 1 — — Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Eden Biologics has made 2 investments. Their most recent investment was on Jun 1, 2016, when Zeus Living raised $2.62M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 1, 2016 Zeus Living
Seed $2.62M Home Decor —
Jul 26, 2013 Zenefits
Seed $2.10M Health Insurance —

Investors

Number of Lead Investors
Number of Investors
1
1
Eden Biologics is funded by 1 investors. Sanofi are the most recent investors.
Investor Name Lead Investor Funding Round
Sanofi Yes Post-IPO Equity
Cointime
Chủ Đề
Công Ty